Description
Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology as a DNA plasmid production platform.
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $298,514 at start, $298,514 after amendment #1 (+$0).
- #02023-01-02$298,514
- #12023-12-14$298,514
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2023-01-02(start date) | $298,514 | — | Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology a… |
| #1 amendment | 2023-12-14 | $298,514 | +$0 | Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology a… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 760829879)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2026-2027-Q1-1043376 | National Research Council Canada | Conseil national de recherches Canada · Canadian International Innovation Program | $600,000 | FY2027 |
| 172-2025-2026-Q4-1040912 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program | $3,975 | FY2026 |
| 172-2025-2026-Q1-1028954 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program | $514,123 | FY2026 |
| 276-2024-2025-Q3-00137 | Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique · REGI - Strategic Growth Initiative (SGI) | $50,000 | FY2025 |
| 172-2023-2024-Q4-1016236 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $349,715 | FY2025 |
| 172-2023-2024-Q4-1014691 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $50,000 | FY2024 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2022-2023-Q4-999756 · retrieved 2026-11-13.